Evidence map›Paper›PMID 19719778›Full record

ReviewBritish journal of pharmacology2009

Role of protein kinase C in functional selectivity for desensitization at the mu-opioid receptor: from pharmacological curiosity to therapeutic potential.

Susan L Ingram, John R Traynor

Open access · bronzeAbstract readCommentReview
In one paragraph

Review in British journal of pharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Coincident Regulation of PLCMolecular pharmacology · 2022
    Article
  3. Article
  4. Review
  5. Review
  6. Chronic methadone treatment shows a better cost/benefit ratio than chronic morphine in mice.The Journal of pharmacology and experimental therapeutics · 2012
    Article
  7. Article
  8. GPCR theme editorial.British journal of pharmacology · 2009
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Susan L IngramDepartment of Psychology, Washington State University Vancouver, Vancouver, WA, USA.
John R Traynor
University of Michigan–Ann Arbor · USWashington State University Vancouver · US

Funding

OPIOID RECEPTOR MECHANISMSR01DA004087 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TRAYNOR, JOHN R. · 1987 to 2010
$2.5M
Psychostimulants induce long-term changes in nociception.R01DA027625 · NIDA · WASHINGTON STATE UNIVERSITY · PI AICHER, SUE A, INGRAM, SUSAN L · 2009 to 2013
$2.3M
Dendritic DAT activity monitored with fluorescent biosensorsR01DA024041 · NIDA · WASHINGTON STATE UNIVERSITY · PI INGRAM, SUSAN L · 2008 to 2012
$1.6M
NIDA NIH HHS DA-024041NIDA NIH HHS DA-04087NIDA NIH HHS R01 DA004087NIDA NIH HHS R01 DA024041NIDA NIH HHS R01 DA027625
6 · The paper itself

Abstract

Opioid agonists are the best therapy for moderate to severe pain, but clinical use is limited due to the development of tolerance and dependence. For the first time, Bailey and co-workers have demonstrated functional selectivity for agonist-induced desensitization of mu-opioid receptors (MOR) in mature rat locus coeruleus neurons. Native MORs are differentially desensitized through separate, agonist-dependent signalling pathways; desensitization of the morphine-occupied receptor occurs via a protein kinase C alpha-dependent pathway while [D-Ala(2), N-MePhe(4), Gly-ol]enkephalin-mediated desensitization is via a G protein receptor kinase subtype 2-dependent mechanism. These results suggest that MORs adopt separate conformational states that either result in different efficiencies of G protein activation or access to phosphorylation by desensitization machinery (e.g. protein kinase C alpha or G protein receptor kinase subtype 2). Further study of the interaction of protein kinase C with MORs in native neurons will enhance our understanding of agonist-induced functional selectivity for desensitization at MORs and provide important insights into how to selectively modulate agonist efficacy to enhance therapeutic capabilities of opioid drugs.

Indexed as

Analgesics, OpioidAnimalsHumansPain MeasurementProtein Kinase CReceptors, Opioid, muAnalgesics, OpioidProtein Kinase CReceptors, Opioid, mu

Identifiers

PMID19719778
PMCPMC2795246
OpenAlexW2078268669

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.